Three dimensional quantitative structure-activity relationship of HEPT analogues as HIV-1 reverse transcriptase inhibitors

被引:0
|
作者
Meng, G [1 ]
He, YP [1 ]
Chen, FE [1 ]
机构
[1] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
来源
关键词
HIV-1 reverse transcriptase inhibitors; HEPT analogues; CoMFA; 3D-QSAR;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine(HEPT) and its analogues inhibit HIV-1 reverse transcriptase(RT) selectively. A series of HEPT analogues were analyzed in order to disclose the relationship between their structure and the activity. Thirty-two HIV-IRT inhibitors were investigated by means of comparative molecular field analysis (CoMFA). Based upon the active conformation extracted from the HEPT/HIV-IRT complex, all the inhibitors were aligned and minimized in energy. Three kinds of CoMFA models were established and evaluated. The model( I)of steric and electrostatic effects on their activities showed a higher ability to explain and predict the activities of these selective HIV-1 inhibitors than other models, cross-validated R-CV(2) = 0.870, non-cross-validated R-2 = 0.986, F = 294. 546, standard error (SE) = 0.146. The CoMFA model established by examining the steric and electrostatic effect on the structure without considering the effect of pi value shows a very high ability to predict the biological activity for testing set compounds and training set compounds and offers an approach to design the new inhibitors. The CoMFA model revealed that the suitable length of the 1-side chain is crucial for the antiviral activity. And it also showed that the bulkier group in 5-position and the para-position of the 6-phenylthio group is also benefit for the enhancement of the antiviral activity.
引用
收藏
页码:1304 / 1308
页数:5
相关论文
共 22 条
  • [1] A structure-activity relationship study of HEPT-analog compounds with anti-HIV activity
    Alves, CN
    Pinheiro, JC
    Camargo, AJ
    Ferreira, MMC
    da Silva, ABF
    [J]. JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2000, 530 (1-2): : 39 - 47
  • [2] Arnold E, 1996, Drug Des Discov, V13, P29
  • [3] BALZARINI J, 1993, MOL PHARMACOL, V44, P694
  • [4] COX TM, 2000, MOL BIOL MED, P271
  • [5] COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS
    CRAMER, RD
    PATTERSON, DE
    BUNCE, JD
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) : 5959 - 5967
  • [6] ISOLATION OF HUMAN T-CELL LEUKEMIA-VIRUS IN ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    GALLO, RC
    SARIN, PS
    GELMANN, EP
    ROBERTGUROFF, M
    RICHARDSON, E
    KALYANARAMAN, VS
    MANN, D
    SIDHU, GD
    STAHL, RE
    ZOLLAPAZNER, S
    LEIBOWITCH, J
    POPOVIC, M
    [J]. SCIENCE, 1983, 220 (4599) : 865 - 867
  • [7] All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: A 3D QSAR approach
    Gussio, R
    Pattabiraman, N
    Zaharevitz, DW
    Kellogg, GE
    Topol, IA
    Rice, WG
    Schaeffer, CA
    Erickson, JW
    Burt, SK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) : 1645 - 1650
  • [8] Comparative molecular field analysis of HIV-1 reverse transcriptase inhibitors in the class of 1[(2-hydroxyethoxy)-methyl]-6(phenylthio)thymine
    Hannongbua, S
    Lawtrakul, L
    Sotriffer, CA
    Rode, BM
    [J]. QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1996, 15 (05): : 389 - 394
  • [9] QSAR OF HIV INHIBITORS
    HANSCH, C
    ZHANG, LT
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (09) : 1165 - 1169
  • [10] Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants
    Hopkins, AL
    Ren, JS
    Tanaka, H
    Baba, M
    Okamato, M
    Stuart, DI
    Stammers, DK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4500 - 4505